Tetrandrine potentiates the hypoglycemic efficacy of berberine by inhibiting P-glycoprotein function - PubMed (original) (raw)
doi: 10.1248/bpb.b13-00272. Epub 2013 Aug 8.
Affiliations
- PMID: 23924821
- DOI: 10.1248/bpb.b13-00272
Free article
Tetrandrine potentiates the hypoglycemic efficacy of berberine by inhibiting P-glycoprotein function
Yong-Qiang Shan et al. Biol Pharm Bull. 2013.
Free article
Abstract
This study was designed to improve the absorption and hypoglycemic efficacy of berberine (BBR), which is a substrate of P-glycoprotein (P-gp), by combination with a P-gp inhibitor tetrandrine (Tet). Flow cytometry and LC-MS/MS were used to determine the cellular efflux or retention of chemicals. Pharmacokinetic study was performed in ICR mice following oral administration of the study compounds. The hypoglycemic efficacies of the compounds were evaluated in diabetic KK-Ay mice. In the in vitro experiments, Tet significantly inhibited the efflux and increased the uptake of P-gp substrates rhodamine-123 as well as BBR in MCF7/DOX cells and Caco-2 intestinal cells. Meanwhile, Tet greatly reduced the expression of P-gp in Caco-2 cells. The inhibition of BBR efflux by Tet was translated into improved pharmacokinetics in vivo. When co-administered, Tet dose-dependently increased the average maximum concentration (C(max)) and area under concentration-time curve (AUC₀₋₂₄) of BBR in mice. Tet itself had no impact on glucose metabolism. However, it greatly potentiated the hypoglycemic efficacy of BBR in diabetic KK-Ay mice. In addition, we found that Tet had moderate inhibitory effect on the catalytic activity of CYP3A4, which played a role in the bio-transformation of BBR, and this may also take part in the improvement of the pharmacokinetics of BBR. In summary, combination with P-gp inhibitors such as Tet can improve the pharmacokinetics and hypoglycemic efficacy of BBR greatly; this implicates a feasible strategy for exploring the therapeutic effects of BBR and other pharmaceuticals which are substrates of P-gp.
Similar articles
- Berberine analogue IMB-Y53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein efflux.
Shan YQ, Ren G, Wang YX, Pang J, Zhao ZY, Yao J, You XF, Si SY, Song DQ, Kong WJ, Jiang JD. Shan YQ, et al. Metabolism. 2013 Mar;62(3):446-56. doi: 10.1016/j.metabol.2012.09.009. Epub 2012 Oct 15. Metabolism. 2013. PMID: 23079743 - Enhancement of Berberine Hypoglycemic Activity by Oligomeric Proanthocyanidins.
Zhang H, Wang X, Wang T, Chen K, Wang H, Jia Q, Li Y. Zhang H, et al. Molecules. 2018 Dec 14;23(12):3318. doi: 10.3390/molecules23123318. Molecules. 2018. PMID: 30558158 Free PMC article. - Improvement of intestinal transport, absorption and anti-diabetic efficacy of berberine by using Gelucire44/14: In vitro, in situ and in vivo studies.
Sun J, Bao H, Peng Y, Zhang H, Sun Y, Qi J, Zhang H, Gao Y. Sun J, et al. Int J Pharm. 2018 Jun 10;544(1):46-54. doi: 10.1016/j.ijpharm.2018.04.014. Epub 2018 Apr 11. Int J Pharm. 2018. PMID: 29654898 - Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies.
Pirillo A, Catapano AL. Pirillo A, et al. Atherosclerosis. 2015 Dec;243(2):449-61. doi: 10.1016/j.atherosclerosis.2015.09.032. Epub 2015 Sep 30. Atherosclerosis. 2015. PMID: 26520899 Review. - Predicting drug-drug interactions involving the inhibition of intestinal CYP3A4 and P-glycoprotein.
Tachibana T, Kato M, Takano J, Sugiyama Y. Tachibana T, et al. Curr Drug Metab. 2010 Nov;11(9):762-77. doi: 10.2174/138920010794328922. Curr Drug Metab. 2010. PMID: 21189139 Review.
Cited by
- A Review of Fibraurea tinctoria and Its Component, Berberine, as an Antidiabetic and Antioxidant.
Purwaningsih I, Maksum IP, Sumiarsa D, Sriwidodo S. Purwaningsih I, et al. Molecules. 2023 Jan 29;28(3):1294. doi: 10.3390/molecules28031294. Molecules. 2023. PMID: 36770960 Free PMC article. Review. - Berberine as a Potential Agent for the Treatment of Colorectal Cancer.
Jiang X, Jiang Z, Jiang M, Sun Y. Jiang X, et al. Front Med (Lausanne). 2022 Apr 28;9:886996. doi: 10.3389/fmed.2022.886996. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35572960 Free PMC article. Review. - The Antioxidant and Hepatoprotective Potential of Berberine and Silymarin on Acetaminophen Induced Toxicity in Cyprinus carpio L.
Grădinariu L, Dediu L, Crețu M, Grecu IR, Docan A, Istrati DI, Dima FM, Stroe MD, Vizireanu C. Grădinariu L, et al. Animals (Basel). 2024 Jan 24;14(3):373. doi: 10.3390/ani14030373. Animals (Basel). 2024. PMID: 38338016 Free PMC article. - In Vivo Toxicity of Solasonine and Its Effects on cyp450 Family Gene Expression in the Livers of Male Mice from Four Strains.
Zhong Y, Li S, Chen L, Liu Z, Luo X, Xu P, Chen L. Zhong Y, et al. Toxins (Basel). 2018 Nov 23;10(12):487. doi: 10.3390/toxins10120487. Toxins (Basel). 2018. PMID: 30477109 Free PMC article. - Inhibitory Effect of Berberine on Broiler P-glycoprotein Expression and Function: In Situ and In Vitro Studies.
Zhang Y, Guo L, Huang J, Sun Y, He F, Zloh M, Wang L. Zhang Y, et al. Int J Mol Sci. 2019 Apr 22;20(8):1966. doi: 10.3390/ijms20081966. Int J Mol Sci. 2019. PMID: 31013627 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous